Colgate Palmolive (India) / Q4-FY24

Read the quarter in context.

A source-linked quarter view: reported numbers, management language, guidance, and the risks that should carry forward.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

Positive2024-05-17Back to COLPAL

Revenue

₹1,481 Cr

verification pending

Revenue YoY

10.7%

reported change

EBITDA

Pending

latest reported figure

Source

manual review required

record provenance

Actual signal trajectory

Where this quarter sits.

source records only
Revenue (₹ Cr)PositiveWatchNegative
2 actual records
Actual quarterly Revenue (₹ Cr) trajectoryReported values plotted by quarter. Hover or focus a point for its quarter, value, and source sentiment.Q4 FY24: 1,481 · Positive source sentiment · 2024-05-17Q4 FY24Q4 FY25: 1,452 · Watch source sentiment · 2025-05-22Q4 FY251,4811,452
Values are taken from the available verified source records; sentiment color is a separate source-read indicator.

Quarter read

What the record says.

Colgate delivered a strong Q4 with 10.7% domestic revenue growth and record EBITDA margins of 35.9%, expanding 250 bps YoY. Full-year revenue grew 9.5%, the highest in recent years, driven by double-digit toothpaste growth, premiumization (Total, Visible White), and a 20% increase in advertising. Management emphasized category expansion via 'brush at night' campaigns and rural recovery (rural outpacing urban by ~200 bps). Personal care (Palmolive) is gaining traction with new variants and media support. Margin expansion was aided by cost savings and pricing, but management flagged that further expansion will moderate. Key risk: sustained margin expansion may be limited as cost savings are reinvested into brand building and product upgrades.

Colored figures show movement against the previous available record.

Guidance to track

  • Management targets premium brands (Total, Visible White) to grow at 2.5-3 times the rate of the core portfolio, currently exceeding that target.
  • Rural markets are growing faster than urban by about 200 basis points, expected to be sustainable with improving macros.
  • Management indicated that the large margin expansion seen in FY24 is a one-off; margins are expected to stay in the current ballpark rather than expand further.
  • Personal care (Palmolive) is growing faster than oral care and the growth gap is expected to widen in coming quarters.

Risks flagged

  • Management explicitly stated that the 400 bps margin expansion is a one-off and margins will likely stabilize, not continue expanding at the same pace.
  • Despite repeated analyst requests, management declined to break down revenue into volume, price, and mix, creating uncertainty about underlying volume trends.
  • An analyst raised concerns about disruption in the body wash category from value players; management downplayed it, citing low penetration, but the segment remains competitive.
  • Only 12% of toothpaste sales are above INR 140 index; premiumization depends on consumer willingness to upgrade, which may be slower in a price-sensitive market.

Key quotes

  • We are the leaders of the oral care category by far. Like I've said numerous times during this presentation, that's both a privilege and a responsibility for us to take this very important category forward in this country.
  • If you are looking for a perspective on our margins going to continue to expand at the rate that they have between last year and this year, the answer is most definitely not.
  • We do expect the category growth, consumption growth activities that we've initiated along with positive macros in rural that we're seeing rural grow faster than urban, and we continue to see green shoots there.

Research modules

Go one layer deeper.